Richard Hancock
Director/Board Member at AVID BIOSERVICES, INC.
Net worth: 562 346 $ as of 2024-06-29
Profile
Richard B.
Hancock is currently the Chairman at Argonaut Manufacturing Services, Inc. and the Director at Tempo Therapeutics, Inc. He previously worked as the President & Chief Executive Officer at Ajinomoto Althea, Inc. from 2012 to 2013.
He also held positions as Senior Director-Operations at Orchestra Therapeutics, Inc., Principal at Genetics Institute LLC, and Principal at Hybritech, Inc. Additionally, he worked as a Clinical Microbiologist at Scripps Clinic & Research Foundation.
Mr. Hancock completed his undergraduate degree at the University of Miami.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
AVID BIOSERVICES, INC.
0.12% | 2023-12-14 | 78,760 ( 0.12% ) | 562 346 $ | 2024-06-29 |
Richard Hancock active positions
| Companies | Position | Start |
|---|---|---|
| AVID BIOSERVICES, INC. | Director/Board Member | 2017-11-26 |
Argonaut Manufacturing Services, Inc.
 Argonaut Manufacturing Services, Inc. Miscellaneous Commercial ServicesCommercial Services Argonaut Manufacturing Services, Inc. engages in providing contract manufacturing in the life science and biotech arena. It offers products launch, scale-up & volume, decline and sunset services. The company was founded in 2016 and is headquartered in Carlsbad, CA. | Chairman | - |
Tempo Therapeutics, Inc.
 Tempo Therapeutics, Inc. BiotechnologyHealth Technology Tempo Therapeutics, Inc. engages in development of materials that are immune stealth, minimally invasive, and precision engineered for regenerative medicine. Its pipeline TT101, TT102, TT201. and TT301. The company was founded by Westbrook Weaver, Philip Scumpia, Dino Di Carlo, Tatiana Segura, and Donald Griffin and is headquartered in San Diego, CA. | Director/Board Member | 2016-05-31 |
Former positions of Richard Hancock
| Companies | Position | End |
|---|---|---|
Ajinomoto Althea, Inc.
 Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Chief Executive Officer | 2012-12-31 |
| Scripps Clinic & Research Foundation | Corporate Officer/Principal | - |
Orchestra Therapeutics, Inc.
 Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Corporate Officer/Principal | - |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Training of Richard Hancock
| University of Miami | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AVID BIOSERVICES, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Finance |
Hybritech, Inc.
Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Commercial Services |
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Health Technology |
| Scripps Clinic & Research Foundation | |
Argonaut Manufacturing Services, Inc.
Argonaut Manufacturing Services, Inc. Miscellaneous Commercial ServicesCommercial Services Argonaut Manufacturing Services, Inc. engages in providing contract manufacturing in the life science and biotech arena. It offers products launch, scale-up & volume, decline and sunset services. The company was founded in 2016 and is headquartered in Carlsbad, CA. | Commercial Services |
Tempo Therapeutics, Inc.
Tempo Therapeutics, Inc. BiotechnologyHealth Technology Tempo Therapeutics, Inc. engages in development of materials that are immune stealth, minimally invasive, and precision engineered for regenerative medicine. Its pipeline TT101, TT102, TT201. and TT301. The company was founded by Westbrook Weaver, Philip Scumpia, Dino Di Carlo, Tatiana Segura, and Donald Griffin and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Richard Hancock
